1. Home
  2. ADXN vs GTBP Comparison

ADXN vs GTBP Comparison

Compare ADXN & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • GTBP
  • Stock Information
  • Founded
  • ADXN 2002
  • GTBP 1965
  • Country
  • ADXN Switzerland
  • GTBP United States
  • Employees
  • ADXN N/A
  • GTBP N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADXN Health Care
  • GTBP Health Care
  • Exchange
  • ADXN Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • ADXN 8.0M
  • GTBP 4.9M
  • IPO Year
  • ADXN N/A
  • GTBP N/A
  • Fundamental
  • Price
  • ADXN $6.73
  • GTBP $2.19
  • Analyst Decision
  • ADXN Strong Buy
  • GTBP Strong Buy
  • Analyst Count
  • ADXN 1
  • GTBP 1
  • Target Price
  • ADXN $30.00
  • GTBP $11.00
  • AVG Volume (30 Days)
  • ADXN 24.1K
  • GTBP 236.8K
  • Earning Date
  • ADXN 03-24-2025
  • GTBP 03-25-2025
  • Dividend Yield
  • ADXN N/A
  • GTBP N/A
  • EPS Growth
  • ADXN N/A
  • GTBP N/A
  • EPS
  • ADXN 0.06
  • GTBP N/A
  • Revenue
  • ADXN $701,260.00
  • GTBP N/A
  • Revenue This Year
  • ADXN N/A
  • GTBP N/A
  • Revenue Next Year
  • ADXN N/A
  • GTBP N/A
  • P/E Ratio
  • ADXN $1.00
  • GTBP N/A
  • Revenue Growth
  • ADXN N/A
  • GTBP N/A
  • 52 Week Low
  • ADXN $6.81
  • GTBP $1.72
  • 52 Week High
  • ADXN $27.90
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 48.97
  • GTBP 43.93
  • Support Level
  • ADXN $7.49
  • GTBP $2.03
  • Resistance Level
  • ADXN $7.86
  • GTBP $2.38
  • Average True Range (ATR)
  • ADXN 0.44
  • GTBP 0.20
  • MACD
  • ADXN 0.01
  • GTBP 0.01
  • Stochastic Oscillator
  • ADXN 47.96
  • GTBP 40.43

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: